📰 Nasdaq Slrn News
Nasdaq Slrn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Slrn. Real-time updates on events, politics, business and more.
April 10, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $5.61 and last traded at $5.67, with a volume of 81890 shares changing hands. The stock had previously closed at $5.95. Wall Street Analysts Forecast Growth A number of research analysts have […]
February 28, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among […]
February 28, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among […]
February 20, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) traded down 8.6% on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Analyst Upgrades and Downgrades A […]
February 20, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s stock price fell 8.6% during trading on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Wall Street […]
February 1, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s share price was up 8% during mid-day trading on Thursday . The company traded as high as $8.24 and last traded at $8.23. Approximately 702,455 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 1,040,443 shares. The stock had previously closed […]
January 23, 2024
Acelyrin (NASDAQ:SLRN – Get Free Report) and Pfizer (NYSE:PFE – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent ratings and […]
January 9, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective […]
January 9, 2024
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among […]
December 27, 2023
Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $7.78, but opened at $7.54. Acelyrin shares last traded at $7.78, with a volume of 32,043 shares changing hands. Analysts Set New Price Targets A number of research analysts have recently commented on […]